Improving Protocol Design Feasibility to Drive Drug Development Economics and Performance.¶
Getz, K. (2014). Improving Protocol Design Feasibility to Drive Drug Development Economics and Performance. International Journal of Environmental Research and Public Health, 11(5), 5069-5080.
Cited by¶
1 citation across 1 artifact.
Primes¶
- Second-System Effect
- and protocols that accrete procedures this way are measurably harder to complete — a finding from industry trials whose complexity is driven by sponsor teams rather than by reviewers, so the join between the two is this entry's inference rather than a documented chain.
SupportedVerified against the work's full text
Getz reports Tufts CSDD data that only 48% of volunteers complete complex protocols versus two-thirds for simpler ones, in industry trials where sponsor clinical teams add the procedures.
“And whereas three-out-of-four volunteers are randomized following screening and two-thirds of volunteers complete simpler protocols; 59% are randomized and less than half (48%) complete complex protocols”
- and protocols that accrete procedures this way are measurably harder to complete — a finding from industry trials whose complexity is driven by sponsor teams rather than by reviewers, so the join between the two is this entry's inference rather than a documented chain.
Verification¶
Does it exist? Confirmed. This work's DOI resolves to a registered record, which fixes its identity. That is all it fixes.
Does it back the claim? Read against the text for 1 of 1 citation: 1 supported. Each verdict is shown under its citation below, with what in the work backs the sentence.
Support is checked per citation rather than per work — the same source can be cited soundly in one article and wrongly in another. Per-citation recording began recently, so a citation with no recorded check is a gap in the record rather than evidence it went unchecked.
See how references were verified.
Registry ID ref:6314a1cabe51 · see in the full table